Evidence map›Paper›PMID 38674585›Full record

ArticleMicroorganisms2024

Device-Associated Infections in COVID-19 Patients: Frequency of Resistant Bacteria, Predictors and Mortality in Medellín, Colombia.

Diana Patricia Ocampo, Lina María Echeverri-Toro, Judy Natalia Jiménez, Lorena Salazar, Carlos Vargas, Gustavo Roncancio, Maria Alejandra Roa, Johanna Marcela Vanegas

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Diana Patricia OcampoFaculty of Medicine, School of Health Sciences, Pontifical Bolivarian University, Medellín 050031, Colombia.
Lina María Echeverri-ToroFaculty of Medicine, School of Health Sciences, Pontifical Bolivarian University, Medellín 050031, Colombia.ORCID 0000-0002-3411-9179
Judy Natalia JiménezResearch Group in Basic and Applied Microbiology, School of Microbiology, University of Antioquia, Medellín 050010, Colombia.
Lorena SalazarResearch Group in Basic and Applied Microbiology, School of Microbiology, University of Antioquia, Medellín 050010, Colombia.ORCID 0000-0002-1682-4915
Carlos VargasSchool of Health Sciencies, Remington University Corporation, Medellín 050010, Colombia.
Gustavo RoncancioFaculty of Medicine, School of Health Sciences, Pontifical Bolivarian University, Medellín 050031, Colombia.ORCID 0000-0002-2677-6398
Maria Alejandra RoaSecretaría de Salud, Medellín 050010, Colombia.
Johanna Marcela VanegasFaculty of Medicine, School of Health Sciences, Pontifical Bolivarian University, Medellín 050031, Colombia.
Universidad Pontificia Bolivariana · COUniversidad de Antioquia · COCorporación Universitaria Remington · COSecretaría de Salud de Bogotá · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIncreased antimicrobial use during the COVID-19 pandemic has raised concerns about the spread of resistant bacteria. This study analyzed the frequency of device-associated infections (DAI) caused by resistant bacteria, the predictors of these infections, and 30-day all-cause mortality in patients with and without COVID-19.

methodsA retrospective cohort study was conducted on DAI patients admitted to the ICU (intensive care unit) in 20 hospitals in Medellin, Colombia (2020-2021). The exposure assessed was the COVID-19 diagnosis, and outcomes analyzed were resistant bacterial infections and 30-day mortality. Clinical and microbiological information was collected from surveillance databases. Statistical analysis included generalized linear mixed-effects models.

resultsOf the 1521 patients included, 1033 (67.9%) were COVID-19-positive and 1665 DAI were presented. Carbapenem-resistant

conclusionCRE infections were predominant in COVID-19 patients. In pandemic situations, the strategies to control DAI should be maintained to avoid infections caused by resistant bacteria, such as length of stay in the ICU and duration of mechanical ventilation.

Indexed as

bacterial resistancecarbapenemasesCOVID-19device-associated infectionshealthcare-associated infections

Identifiers

PMID38674585
PMCPMC11051839
OpenAlexW4393160864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.